Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Butour

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Biochemical and Biophysical Research Communications|November 27, 1985
Kinetics of the reaction of cis-platinum compounds with DNA in vitroJ L Butour, A M Mazard, J P Macquet
Biophysical Chemistry|April 1, 1990
Biophysical studies of the modification of DNA by antitumour platinum coordination complexesV Brabec, V Kleinwächter, J L Butour, et al.
Chemico-Biological Interactions|May 2, 1997
Palladium(II) compounds with potential antitumour properties and their platinum analogues: a comparative study of the reaction of some orotic acid derivatives with DNA in vitroJ L Butour, S Wimmer, F Wimmer, et al.
Mutation Research|April 1, 1977
Relative efficiencies of a series of square-planar plantinum(II) compounds on Salmonella mutagenesisP Lecointe, J P Macquet, J L Butour, et al.
Biochemical and Biophysical Research Communications|April 29, 1983
cis-Pt(NH3)2Cl2 and trans-Pt(NH3)2Cl2 inhibit DNA synthesis in cultured L1210 leukemia cellsB Salles, J L Butour, C Lesca, et al.
European Journal of Pharmacology|July 21, 1998
[Phe1psi(CH2-NH)Gly2]nociceptin-(1-13)-NH2 is an agonist of the nociceptin (ORL1) receptorJ L Butour, C Moisand, C Mollereau, et al.
FEBS Letters|June 2, 1998
Different domains of the ORL1 and kappa-opioid receptors are involved in recognition of nociceptin and dynorphin AS Lapalu, C Moisand, J L Butour, et al.
Chemico-Biological Interactions|January 1, 1990
Kinetic studies of the hydrolysis of platinum-DNA complexes by nuclease S1J L Butour, A M Mazard, C Vieussens, et al.
European Journal of Pharmacology|February 19, 1997
Recognition and activation of the opioid receptor-like ORL 1 receptor by nociceptin, nociceptin analogs and opioidsJ L Butour, C Moisand, H Mazarguil, et al.
FEBS Letters|October 14, 1996
Replacement of Gln280 by His in TM6 of the human ORL1 receptor increases affinity but reduces intrinsic activity of opioidsC Mollereau, C Moisand, J L Butour, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Biochemical and Biophysical Research Communications|November 27, 1985
Kinetics of the reaction of cis-platinum compounds with DNA in vitroJ L Butour, A M Mazard, J P Macquet
Biophysical Chemistry|April 1, 1990
Biophysical studies of the modification of DNA by antitumour platinum coordination complexesV Brabec, V Kleinwächter, J L Butour, et al.
Chemico-Biological Interactions|May 2, 1997
Palladium(II) compounds with potential antitumour properties and their platinum analogues: a comparative study of the reaction of some orotic acid derivatives with DNA in vitroJ L Butour, S Wimmer, F Wimmer, et al.
Mutation Research|April 1, 1977
Relative efficiencies of a series of square-planar plantinum(II) compounds on Salmonella mutagenesisP Lecointe, J P Macquet, J L Butour, et al.
Biochemical and Biophysical Research Communications|April 29, 1983
cis-Pt(NH3)2Cl2 and trans-Pt(NH3)2Cl2 inhibit DNA synthesis in cultured L1210 leukemia cellsB Salles, J L Butour, C Lesca, et al.
European Journal of Pharmacology|July 21, 1998
[Phe1psi(CH2-NH)Gly2]nociceptin-(1-13)-NH2 is an agonist of the nociceptin (ORL1) receptorJ L Butour, C Moisand, C Mollereau, et al.
FEBS Letters|June 2, 1998
Different domains of the ORL1 and kappa-opioid receptors are involved in recognition of nociceptin and dynorphin AS Lapalu, C Moisand, J L Butour, et al.
Chemico-Biological Interactions|January 1, 1990
Kinetic studies of the hydrolysis of platinum-DNA complexes by nuclease S1J L Butour, A M Mazard, C Vieussens, et al.
European Journal of Pharmacology|February 19, 1997
Recognition and activation of the opioid receptor-like ORL 1 receptor by nociceptin, nociceptin analogs and opioidsJ L Butour, C Moisand, H Mazarguil, et al.
FEBS Letters|October 14, 1996
Replacement of Gln280 by His in TM6 of the human ORL1 receptor increases affinity but reduces intrinsic activity of opioidsC Mollereau, C Moisand, J L Butour, et al.
Pageof 3